News
European research led by University College London (UCL), together with Amsterdam UMC and the University of Basel, shows that ...
Terumo Neuro (formerly MicroVention) announced today that it received FDA premarket approval (PMA) for its Carotid Stent ...
A new study published in Nature Cardiovascular Research found that while carotid artery narrowing can lead to stroke in both ...
10h
News-Medical.Net on MSNMany stroke patients with carotid artery narrowing may avoid surgery, research showsEuropean research led by University College London (UCL), together with Amsterdam UMC and the University of Basel shows that a significant proportion of patients who suffer a stroke due to carotid ...
European research led by University College London (UCL), together with Amsterdam UMC and the University of Basel shows that a significant proportion ...
Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced that their Carotid Stent System has received Premarket Approval (PMA) ...
11h
News-Medical.Net on MSNNew scoring system predicts stroke risk and reduces need for surgeryResearchers at UCL have tested a new scoring system to measure the risk of stroke in patients with narrowed arteries due to ...
Applied during the surgery for people averaging 80% internal carotid artery stenosis, sonolysis resulted in reductions in 30-day: Combined ischemic stroke, transient ischemic attack (TIA), and ...
The most effective treatment for carotid artery stenosis is carotid endarterectomy (CEA). To date, randomized trials of this procedure versus best medical care have excluded patients aged 80 years ...
This cross-sectional study, spanning from December 2020 to December 2021, delves into the prevalence and risk factors of carotid artery stenosis and plaque across China. Involving 194,878 adults aged ...
The investigators randomized 1,004 patients (mean age 68 years; 31% women) with symptomatic or asymptomatic internal carotid artery stenosis ≥ 70% to either sonolysis or a sham intervention during ...
Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results